Literature DB >> 21047219

Picking up the pace--scale-up of MDR tuberculosis treatment programs.

Salmaan Keshavjee1, Paul E Farmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21047219     DOI： 10.1056/NEJMp1010023

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.

Authors:  J C M Brust; N S Shah; M Scott; K Chaiyachati; M Lygizos; T L van der Merwe; S Bamber; Z Radebe; M Loveday; A P Moll; B Margot; U G Lalloo; G H Friedland; N R Gandhi
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-05       Impact factor: 2.373

2.  Linking surveillance with action against drug-resistant tuberculosis.

Authors:  Ted Cohen; Justin Manjourides; Bethany Hedt-Gauthier
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

Review 3.  Drug-resistant tuberculosis: an insurmountable epidemic?

Authors:  Amitabha Chakroborty
Journal:  Inflammopharmacology       Date:  2010-12-03       Impact factor: 4.473

Review 4.  Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.

Authors:  Helen E Jenkins; Arielle W Tolman; Courtney M Yuen; Jonathan B Parr; Salmaan Keshavjee; Carlos M Pérez-Vélez; Marcello Pagano; Mercedes C Becerra; Ted Cohen
Journal:  Lancet       Date:  2014-03-24       Impact factor: 79.321

5.  The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.

Authors:  Wei Gao; Jin-Yong Kim; Jeffrey R Anderson; Tatos Akopian; Seungpyo Hong; Ying-Yu Jin; Olga Kandror; Jong-Woo Kim; In-Ae Lee; Sun-Young Lee; James B McAlpine; Surafel Mulugeta; Suhair Sunoqrot; Yuehong Wang; Seung-Hwan Yang; Tae-Mi Yoon; Alfred L Goldberg; Guido F Pauli; Joo-Won Suh; Scott G Franzblau; Sanghyun Cho
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

Review 6.  Alternative methods of diagnosing drug resistance--what can they do for me?

Authors:  David A J Moore; N Sarita Shah
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

7.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

8.  Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.

Authors:  Gustavo E Velásquez; Mercedes C Becerra; Irina Y Gelmanova; Alexander D Pasechnikov; Askar Yedilbayev; Sonya S Shin; Yevgeny G Andreev; Galina Yanova; Sidney S Atwood; Carole D Mitnick; Molly F Franke; Michael L Rich; Salmaan Keshavjee
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

9.  Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Authors:  Helen E Jenkins; Valeriu Plesca; Anisoara Ciobanu; Valeriu Crudu; Irina Galusca; Viorel Soltan; Aliona Serbulenco; Matteo Zignol; Andrei Dadu; Masoud Dara; Ted Cohen
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

10.  Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.

Authors:  Mercedes C Becerra; Soumya Swaminathan
Journal:  J Public Health Policy       Date:  2014-09-11       Impact factor: 2.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.